---
schema_version: "secwatch.filing_event.v1"
accession: "0001171520-22-000126"
form_type: "8-K"
ticker: "CLPT"
cik: "0001285550"
company_name: "ClearPoint Neuro, Inc."
filed_at: "2022-02-14T23:59:59+00:00"
generated_at: "2026-06-27T08:18:47.825249+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# ClearPoint Neuro COO Peter Piferi resigns, will serve as interim head of regulatory under consulting agreement

## Summary
- Peter G. Piferi voluntarily resigned as COO effective Feb 18, 2022; not due to any disagreement with management.
- He entered a consulting agreement effective Feb 21, 2022, for up to 2 months (with possible month-to-month extension up to 2 years).
- Will receive $5,000 cash separation, continued vesting of stock options and restricted stock, and $10,000/month consulting fee.
- Consulting services include transitioning job functions and serving as Interim Head of Regulatory for ClearPoint Neuro.

## SEC filing metadata
- accession: 0001171520-22-000126
- form_type: 8-K
- ticker: CLPT
- cik: 0001285550
- company_name: ClearPoint Neuro, Inc.
- filed_at: 2022-02-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1285550/000117152022000126/0001171520-22-000126-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1285550/000117152022000126/eps10076.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171520-22-000126
- JSON: https://secwatch.observer/filing/0001171520-22-000126.json
- Plain text: https://secwatch.observer/filing/0001171520-22-000126.txt

## Key facts
- Executive change
  Peter G. Piferi resigned as Chief Operating Officer at ClearPoint Neuro, Inc..
  - Action: resigned
  - Role: Chief Operating Officer
  source text: Peter G. Piferi voluntarily resigned from his position as the Chief Operating Officer of ClearPoint Neuro, Inc. (the “Company”) and is separating from the Company, effective as of February 18, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1285550/000117152022000126/0001171520-22-000126-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.